Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1625288/000149315220018396/form10-k.htm
January 2022
July 2020
April 2020
October 2019
July 2019
April 2019
March 2019
March 2019
March 2019
February 2019
Document and Entity Information - USD ($) | 12 Months Ended | ||
---|---|---|---|
Jun. 30, 2020 | Sep. 24, 2020 | Dec. 31, 2019 | |
Cover [Abstract] | |||
Entity Registrant Name | NEXIEN BIOPHARMA, INC. | ||
Entity Central Index Key | 0001625288 | ||
Document Type | 10-K | ||
Document Period End Date | Jun. 30, 2020 | ||
Amendment Flag | false | ||
Current Fiscal Year End Date | --06-30 | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Voluntary Filers | No | ||
Entity Reporting Status Current | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Non-accelerated Filer | ||
Entity Small Business Flag | true | ||
Entity Emerging Growth Company | true | ||
Entity Ex Transition Period | false | ||
Entity Shell Company | false | ||
Entity Public Float | $ 739,977 | ||
Entity Common Stock, Shares Outstanding | 55,781,196 | ||
Document Fiscal Period Focus | FY | ||
Document Fiscal Year Focus | 2020 |
Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1625288/000149315220018396/form10-k.htm
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Nexien Biopharma, Inc..
Nexien Biopharma, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:
Material Contracts, Statements, Certifications & more
Nexien Biopharma, Inc. provided additional information to their SEC Filing as exhibits
Ticker: NXEN
CIK: 1625288
Form Type: 10-K Annual Report
Accession Number: 0001493152-20-018396
Submitted to the SEC: Mon Sep 28 2020 6:10:33 AM EST
Accepted by the SEC: Mon Sep 28 2020
Period: Tuesday, June 30, 2020
Industry: Pharmaceutical Preparations